Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Axitinib
×
90 days
×
Clear all
Filters
3
NCT05017012
2026-01-08
MK-3475A-C18
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
72 enrolled